IGF1 and obesity disorder: Consequently, an increasing body of literature proposes an alternative approach using obesity biomarkers, such as circulating hormones (e.g., adipokines, insulin, and insulin-like growth factor [IGF-1]), to delineate obesity phenotypes associated with an elevated risk of morbidity and mortality.